Abiraterone Tablets
Prostate Cancer
250mg
Abiraterone 250mg tablets, used in the management of prostate cancer. A CYP17A1 inhibitor that blocks androgen synthesis in the adrenal glands.
From$3.15/ tabletView
Abiraterone
Abiraterone (brand name Zytiga) is an orally administered inhibitor used for the management of prostate cancer. These options reflect the primary medical objective of lowering androgen production in patients requiring targeted oncology support.
Key points
- Abiraterone inhibits the CYP17 enzyme to cut androgen production in men with prostate cancer that has advanced past other treatments.
- Treatment is often combined with a steroid medicine to help offset abiraterone’s systemic hormonal effects.
- Regular blood tests are used to monitor liver enzymes, blood pressure and fluid retention during treatment.
What is Abiraterone?
Abiraterone is a selective steroid inhibitor utilised in advanced cancer care. It focuses on disrupting the production of androgens, which are hormones that the body sometimes relies on to stimulate the growth of specific tissue types. The variety of available formulations allows patients and providers to adhere to consistent treatment protocols.
What Abiraterone is used for
Abiraterone is primarily utilised in the management of Prostate Cancer. It is indicated for patients where the condition has progressed despite other non-invasive interventions, often in combination with steroid therapy to manage systemic responses.
How does Abiraterone work?
This medication works by inhibiting an enzyme called CYP17, which is responsible for the production of androgens in the body. By reducing these hormone levels, the medication limits the internal drivers that encourage the growth of certain prostate cells. This mechanism serves as a cornerstone of broader Oncology Support.
Abiraterone brands and forms
Abiraterone is marketed under the brand Zytiga and appears as generic Tablet; Film-coated tablet formulations. While the brand sets the originator standard, generic alternatives provide consistent active ingredients for patients receiving care within the oncology spectrum. The film-coated tablet form is designed to ensure stability and precise delivery of the compound.
Safety overview for Abiraterone
What to check before using this medicine
Verify that the medication is suitable for your specific health history, particularly regarding liver or heart function. Ensure the dose aligns with the regimen specified by a provider to avoid unwanted physiological stress.
Possible reactions and tolerability
Common responses may include changes in blood pressure, fluid retention or alterations in liver enzyme levels. Monitoring these markers periodically via blood testing is standard clinical practice to ensure ongoing tolerability.
Interactions and health factors
Abiraterone may interact with other medications or supplements that affect hormone levels or liver engagement. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.